Published in Semin Arthritis Rheum on August 24, 2011
Statins accelerate the onset of collagen type II-induced arthritis in mice. Arthritis Res Ther (2012) 1.18
Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approach. PLoS One (2012) 0.84
Statin use and markers of immunity in the Doetinchem cohort study. PLoS One (2013) 0.76
Role of interleukin-12 and - 18 in lupus-like syndrome patients with statin use: comment on: Association between statin use and lupus-like syndrome using spontaneous reports. Semin Arthritis Rheum (2012) 0.75
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med (2010) 8.64
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med (2003) 7.30
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum (2005) 4.21
Instrumental variables: application and limitations. Epidemiology (2006) 3.03
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction. J Hypertens (2009) 2.14
Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med (2007) 2.09
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. Eur Heart J (2010) 2.00
Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol (2011) 1.94
The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials (2011) 1.87
Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis. Arthritis Rheum (2004) 1.70
Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction. Eur Heart J (2012) 1.67
Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol (2005) 1.65
Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health. Br J Nutr (2013) 1.64
Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J (2013) 1.58
Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens (2005) 1.58
Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis (2005) 1.57
Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest (2013) 1.55
Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins Leukot Essent Fatty Acids (2009) 1.54
Intranasally administered corticosteroids and neuropsychiatric disturbances: a review of the international pharmacovigilance programme of the World Health Organization. Ann Allergy Asthma Immunol (2008) 1.54
Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Saf (2002) 1.51
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One (2009) 1.50
Variation in Renin-Angiotensin system and salt-sensitivity genes and the risk of diabetes mellitus associated with the use of thiazide diuretics. Am J Hypertens (2009) 1.50
Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-/- mice. Arterioscler Thromb Vasc Biol (2007) 1.49
Patients with antineutrophil cytoplasmic antibodies associated vasculitis in remission are hypercoagulable. J Rheumatol (2013) 1.49
Effect of oral antiplatelet agents on major bleeding in users of coumarins. Thromb Haemost (2008) 1.48
Generic substitution of antihypertensive drugs: does it affect adherence? Ann Pharmacother (2005) 1.47
Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol (2011) 1.46
Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc (2008) 1.46
Sub-chronic toxicity study in rats orally exposed to nanostructured silica. Part Fibre Toxicol (2014) 1.44
Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism. Atherosclerosis (2004) 1.43
The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress. Cardiovasc Drugs Ther (2007) 1.41
The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol (2008) 1.40
Cardiac involvement in Churg-Strauss syndrome. Arthritis Rheum (2010) 1.38
Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano (2012) 1.34
Drug-induced immune thrombocytopenia. Drug Saf (2004) 1.32
Vascular inflammation in cerebral small vessel disease. Neurobiol Aging (2011) 1.32
Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int (2003) 1.31
Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med (2008) 1.30
Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI. Atherosclerosis (2011) 1.27
Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev (2011) 1.24
Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion. Am J Pathol (2007) 1.24
Status of nutrition and health claims in Europe. Arch Biochem Biophys (2010) 1.24
Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother (2005) 1.23
Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-The Limburg Renal Registry. Kidney Int (2004) 1.19
New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int (2010) 1.19
Statins accelerate the onset of collagen type II-induced arthritis in mice. Arthritis Res Ther (2012) 1.18
Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis. Arthritis Rheum (2002) 1.18
Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol (2013) 1.15
Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res (2001) 1.13
The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev (2009) 1.12
Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia (2006) 1.12
Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review. PLoS One (2010) 1.11
Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study. Arthritis Rheum (2005) 1.10
Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Pharmacoepidemiol Drug Saf (2005) 1.09
Probiotics: immunomodulation and evaluation of safety and efficacy. Nutr Rev (2006) 1.09
Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community. Eur Heart J (2013) 1.08
Refill adherence and polypharmacy among patients with type 2 diabetes in general practice. Pharmacoepidemiol Drug Saf (2009) 1.07
Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. J Neuroimmunol (2009) 1.05
Transcriptomic profile indicative of immunotoxic exposure: in vitro studies in peripheral blood mononuclear cells. Toxicol Sci (2010) 1.05
Reimbursement restriction and moderate decrease in benzodiazepine use in general practice. Ann Fam Med (2012) 1.04
Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation. J Clin Epidemiol (2005) 1.03
The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen. J Hypertens (2004) 1.03
T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells? Arthritis Res Ther (2010) 1.02
Systematic differences in treatment effect estimates between propensity score methods and logistic regression. Int J Epidemiol (2008) 1.01
Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study. Eur Heart J (2006) 1.01
Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. Clin J Am Soc Nephrol (2007) 1.00
The role of Toll-like receptor-4 in pertussis vaccine-induced immunity. BMC Immunol (2008) 0.99
Measuring balance and model selection in propensity score methods. Pharmacoepidemiol Drug Saf (2011) 0.99
The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin (2008) 0.99
Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression. Int J Food Microbiol (2006) 0.98
Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats. Biomaterials (2013) 0.98
Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. J Steroid Biochem Mol Biol (2010) 0.98
Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide. Ann Rheum Dis (2006) 0.98
Allergic reactions to medicines derived from Pelargonium species. Drug Saf (2007) 0.97
Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Bone (2010) 0.97
The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting. Pharmacogenet Genomics (2012) 0.97
Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Ann N Y Acad Sci (2009) 0.96
Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J Invest Dermatol (2004) 0.96
Suboptimal choices and dosing of statins at start of therapy. Br J Clin Pharmacol (2005) 0.96
CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis. Nephrol Dial Transplant (2008) 0.96
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol (2002) 0.96
Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution. Br J Clin Pharmacol (2007) 0.95
Prenatal exposure to polychlorinated biphenyls and dioxins from the maternal diet may be associated with immunosuppressive effects that persist into early childhood. Food Chem Toxicol (2012) 0.95
Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated? Br J Clin Pharmacol (2002) 0.95
Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study. Pharmacoepidemiol Drug Saf (2014) 0.95
Neutrophils and T cells: bidirectional effects and functional interferences. Mol Immunol (2011) 0.94
Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. J Clin Epidemiol (2009) 0.93
The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. ALTEX (2012) 0.93
The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study. Pharmacogenet Genomics (2014) 0.93
Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection? Trends Immunol (2005) 0.93
Autoantibody detection in bullous pemphigoid: clinical evaluation of the EUROPLUS™ Dermatology Mosaic. J Immunol Methods (2012) 0.93